Vol. 138, No. 48 — November 27, 2004

COMMISSIONS

CANADIAN INTERNATIONAL TRADE TRIBUNAL

EXPIRY REVIEW OF FINDING

Dishwashers and dryers

The Canadian International Trade Tribunal (the Tribunal) hereby gives notice that it will, pursuant to subsection 76.03(3) of the Special Import Measures Act (SIMA), initiate an expiry review (Expiry Review No. RR-2004-005) of its finding made on August 1, 2000, in Inquiry No. NQ-2000-001, as amended on March 19, 2003, in Interim Review No. RD-2002-005, concerning certain electric household dishwashers and gas or electric laundry dryers originating in or exported from the United States of America and produced by, or on behalf of, White Consolidated Industries, Inc. and Whirlpool Corporation, their respective affiliates, successors and assigns.

Notice of Expiry No. LE-2004-006, issued on September 28, 2004, informed interested persons and governments of the impending expiry of the finding. On the basis of available information, including representations requesting or opposing the initiation of an expiry review and responses to these representations received by the Tribunal in reply to the notice, the Tribunal is of the opinion that a review of the finding is warranted. The Tribunal has notified the Canada Border Services Agency (CBSA), as well as other interested persons and governments, of its decision.

The Tribunal has issued a Draft Guideline on Expiry Reviews that can be found on the Tribunal's Web site at www.citt-tcce.gc.ca. In this expiry review, the CBSA must determine whether the expiry of the finding in respect of certain dishwashers and dryers is likely to result in the continuation or resumption of dumping of the goods.

If the CBSA determines that the expiry of the finding in respect of any goods is likely to result in the continuation or resumption of dumping, the CBSA will provide the Tribunal with the information that is required under the Canadian International Trade Tribunal Rules. The Tribunal will then conduct an inquiry to determine if the continued or resumed dumping is likely to result in injury or retardation.

If the CBSA determines that the expiry of the finding in respect of any goods is unlikely to result in the continuation or resumption of dumping, the Tribunal will not consider those goods in its subsequent determination of the likelihood of injury or retardation and will issue an order rescinding the finding with respect to those goods.

The CBSA must provide notice of its determination within 120 days after receiving notice of the Tribunal's decision to initiate an expiry review, that is, no later than March 17, 2005. The CBSA will also notify all persons or governments that were notified by the Tribunal of the commencement of an expiry review, as well as any others that participated in the CBSA's investigation.

Letters have been sent to parties with a known interest in the expiry review providing them with the schedule respecting both the CBSA's investigation and the Tribunal's inquiry, should the CBSA determine that the expiry of the finding in respect of any goods is likely to result in a continuation or resumption of dumping.

The CBSA's investigation

The CBSA will conduct its investigation pursuant to the provisions of SIMA and the administrative guidelines set forth in the Anti-dumping and Countervailing Directorate's publication entitled Guidelines on the Conduct of Expiry Review Investigations under the Special Import Measures Act. Any information submitted to the CBSA by interested persons concerning this investigation is deemed to be public information unless clearly designated as confidential. Where the submission is confidential, a non-confidential edited version or summary of the submission must also be provided which will be disclosed to interested parties upon request.

With respect to the CBSA's investigation, the schedule specifies, among other things, the date for the filing of replies to the expiry review questionnaires, the date on which the CBSA exhibits will be available to parties to the proceeding, the date on which the administrative record will be closed and the dates for the filing of submissions by parties in the proceeding. The expiry review questionnaires for exporters, importers and domestic producer are posted on the CBSA's Web site at http://www.cbsa-asfc.gc.ca/sima/expiry-eng.html.

Tribunal's inquiry

Should the CBSA determine that the expiry of the finding in respect of any goods is likely to result in a continuation or resumption of dumping, the Tribunal will conduct its inquiry, pursuant to the provisions of SIMA and its Draft Guideline on Expiry Reviews, to determine if there is a likelihood of injury or retardation. The schedule for the Tribunal's inquiry specifies, among other things, the date for the filing of replies by the domestic producer to Part E of the expiry review questionnaire, the date on which information on the record will be made available by the Tribunal to interested parties and counsel that have filed notices of participation and the dates for the filing of submissions by interested parties.

The Tribunal's Guide to Making Requests for Product Exclusions, which can be found on the Tribunal's Web site, describes the procedure for filing requests for specific product exclusions. The Guide includes a form for filing requests for product exclusions and a form for any party that opposes a request to respond to such requests. This does not preclude parties from making submissions in a different format if they so wish, provided that all of the information and supporting documentation requested in the forms are included. Requests to exclude goods from the finding shall be filed by interested parties no later than May 17, 2005. Parties opposed or consenting or not opposed to the request for exclusion shall file written reply submissions no later than May 26, 2005. Should the request for a specific product exclusion be opposed, and if the interested party wishes to reply, it must do so within a period determined by the Tribunal in advance of the hearing.

Under section 46 of the Canadian International Trade Tribunal Act, a person who provides information to the Tribunal and who wishes some or all of the information to be kept confidential must submit to the Tribunal, at the time the information is provided, a statement designating the information as confidential, together with an explanation as to why the information is designated as confidential. Furthermore, the person must submit a non-confidential edited version or non-confidential summary of the information designated as confidential or a statement indicating why such an edited version or summary cannot be made.

Public hearing

The Tribunal will hold a public hearing relating to this expiry review in the Tribunal Hearing Room, 18th Floor, Standard Life Centre, 333 Laurier Avenue W, Ottawa, Ontario, commencing on June 6, 2005, at 9:30 a.m., to hear evidence and representations by interested parties.

Each interested person or government wishing to participate at the hearing as a party must file a notice of participation with the Secretary on or before March 24, 2005. Each counsel who intends to represent a party at the hearing must file a notice of representation, as well as a declaration and undertaking, with the Secretary on or before March 24, 2005.

To allow the Tribunal to determine whether simultaneous interpretation will be required for the hearing, each interested person or government filing a notice of participation and each counsel filing a notice of representation must advise the Secretary, at the same time that they file the notice, whether they and their witnesses will be using English or French or both languages at the hearing.

The Canadian International Trade Tribunal Rules govern these proceedings.

In order to observe and understand production processes, the Tribunal, accompanied by its staff, may conduct plant visits.

Communication

Written submissions, correspondence and requests for information regarding the CBSA's investigation should be addressed to Mr. Jan Smith, Senior Program Officer, Anti-dumping and Countervailing Directorate, Canada Border Services Agency, Berger Building, 11th Floor, 100 Metcalfe Street, Ottawa, Ontario K1A 0L8, (613) 954-7409 (telephone), (613) 954-2510 (facsimile), Jan.Smith@ccra-adrc.gc.ca (electronic mail).

A copy of the CBSA's investigation schedule and the expiry review investigation guidelines are available on the CBSA's Web site at www.cbsa-asfc.gc.ca/sima/expiry-eng.html.

Written submissions, correspondence and requests for information regarding the Tribunal's inquiry should be addressed to the Secretary, Canadian International Trade Tribunal, Standard Life Centre, 15th Floor, 333 Laurier Avenue W, Ottawa, Ontario K1A 0G7, (613) 993-3595 (telephone), (613) 990-2439 (facsimile), secretary@citt-tcce.gc.ca (electronic mail).

Written and oral communication with the CBSA and the Tribunal may be in English or in French.

Ottawa, November 17, 2004

HÉLÈNE NADEAU
Secretary

[48-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

NOTICE TO INTERESTED PARTIES

The following notices are abridged versions of the Commission's original notices bearing the same number. The original notices contain a more detailed outline of the applications, including additional locations and addresses where the complete files may be examined. The relevant material, including the notices and applications, is available for viewing during normal business hours at the following offices of the Commission:

— Central Building, Les Terrasses de la Chaudière, Room G-5, 1 Promenade du Portage, Gatineau, Quebec K1A 0N2, (819) 997-2429 (telephone), 994-0423 (TDD), (819) 994-0218 (facsimile);

— Bank of Commerce Building, Suite 1007, 1809 Barrington Street, Halifax, Nova Scotia B3J 3K8, (902) 426-7997 (telephone), 426-6997 (TDD), (902) 426-2721 (facsimile);

— Kensington Building, Suite 1810, 275 Portage Avenue, Winnipeg, Manitoba R3B 2B3, (204) 983-6306 (telephone), 983-8274 (TDD), (204) 983-6317 (facsimile);

— 530-580 Hornby Street, Vancouver, British Columbia V6C 3B6, (604) 666-2111 (telephone), 666-0778 (TDD), (604) 666-8322 (facsimile);

— C.R.T.C. Documentation Centre, 405 De Maisonneuve Boulevard E, 2nd Floor, Suite B2300, Montréal, Quebec H2L 4J5, (514) 283-6607 (telephone), 283-8316 (TDD), (514) 283-3689 (facsimile);

— C.R.T.C. Documentation Centre, 55 St. Clair Avenue E, Suite 624, Toronto, Ontario M4T 1M2, (416) 952-9096 (telephone), (416) 954-6343 (facsimile);

— C.R.T.C. Documentation Centre, Cornwall Professional Building, Room 103, 2125 11th Avenue, Regina, Saskatchewan S4P 3X3, (306) 780-3422 (telephone), (306) 780-3319 (facsimile);

— C.R.T.C. Documentation Centre, 10405 Jasper Avenue, Suite 520, Edmonton, Alberta T5J 3N4, (780) 495-3224 (telephone), (780) 495-3214 (facsimile).

Interventions must be filed with the Secretary General, Canadian Radio-television and Telecommunications Commission, Ottawa, Ontario K1A 0N2, together with proof that a true copy of the intervention has been served upon the applicant, on or before the deadline given in the notice.

Secretary General

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

DECISIONS

The complete texts of the decisions summarized below are available from the offices of the CRTC.

2004-495 November 17, 2004

Central Okanagan Re-Broadcast Society
Winfield, British Columbia

Approved — Renewal of the broadcasting licence for the radiocommunication distribution undertaking serving Winfield, from December 1, 2004, to August 31, 2011.

2004-496 November 18, 2004

Bell Canada
Toronto, Hamilton/Niagara, Oshawa, Kitchener, London, Windsor, Ottawa, and surrounding area at each location in Ontario; and Montréal, Gatineau, Sherbrooke, Québec, and surrounding area at each location in Quebec

Approved — New terrestrial broadcasting distribution undertakings to serve various communities in Ontario and Quebec. The licences will expire August 31, 2011.

2004-497 November 18, 2004

MediaNet Canada Ltd.
Across Canada

Approved — New national ethnic Category 2 specialty programming undertaking, JTV – Jewish Television. The licence will expire August 31, 2011.

2004-498 November 19, 2004

Milestone Radio Inc.
Toronto, Ontario

Approved — Extension of the time limit to commence the operation of the transitional digital radio undertaking until August 31, 2005.

2004-499 November 19, 2004

Wilderness Ministries Inc.
Nipawin, Saskatchewan

Approved — Technical change of the authorized contours of the radio programming undertaking at Nipawin.

2004-500 November 19, 2004

Radio Nord Communications inc.
Hawkesbury, Ontario

Approved — Technical change of the authorized contours of the radio programming undertaking CHPR-FM Hawkesbury.

2004-501 November 19, 2004

Fawcett Broadcasting Limited
Kenora, Ontario

Approved — Technical change of the authorized contours of the radio programming undertaking CJRL-FM Kenora.

2004-502 November 19, 2004

CHUM Limited, on behalf of Craig Media Inc.
Across Canada

Approved — Transfer of effective control of Craig Media Inc. to CHUM Limited and acquisition of the assets of the television programming undertakings CKXT-TV Toronto and its transmitter CKXT-TV-1 Hamilton, and CKXT-DT Toronto and its transmitter CKXT-DT-1 Hamilton—reorganization of Toronto One.

2004-503 November 19, 2004

TVA Group Inc. and Sun Media Corporation, on behalf of Newco, a wholly owned subsidiary corporation to be incorporated
Toronto, Ontario

Approved — Transfer of effective control of Toronto One to TVA Group Inc. and Sun Media Corporation.

[48-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

PUBLIC NOTICE 2004-87

The Commission has received the following applications. The deadline for submission of interventions/comments is December 20, 2004.

1. CTV Television Inc.
    Across Canada

To amend the broadcasting licence to carry on the national specialty television service known as CTV NewsNet.

2. Canadian Broadcasting Corporation
    Stephenville, Newfoundland and Labrador

To amend the licence of radio programming undertaking CBN-FM St. John's.

November 15, 2004

[48-1-o]

CANADIAN RADIO-TELEVISION AND TELECOMMUNICATIONS COMMISSION

PUBLIC NOTICE 2004-88

Revised lists of eligible satellite services

The Commission approves the addition of the non-Canadian services Fox News and NFL Network to its lists of eligible satellite services for distribution on a digital basis.

The four lists appended to the public notice supersede the lists appended to Revised lists of eligible satellite services, Broadcasting Public Notice CRTC 2004-71, September 16, 2004.

November 18, 2004

[48-1-o]

CANADIAN TRANSPORTATION AGENCY

CANADA TRANSPORTATION ACT

International air cargo transhipment program at Winnipeg International airport

In accordance with the decision to approve participation of Winnipeg International Airport in the federal government's air cargo transhipment program announced by the Minister of Transport on September 27, 2004, notice is hereby given that the Canadian Transportation Agency will consider applications from Canadian and foreign air carriers for authorization to carry international cargo shipments to and from Winnipeg International Airport coming from and destined for points outside the territory of Canada. Such authorization would carry an obligation to report traffic carried to and from Winnipeg in accordance with directions to be advised upon authorization, and an obligation to have sufficient liability insurance coverage in respect of the service to be provided to satisfy the minimum requirements of the Air Transportation Regulations, SOR/88-58, as amended. Such intransit cargo would be held in bond pending its onward transportation to its destination.

Application may be made by letter addressed to the Secretary, Canadian Transportation Agency, Ottawa, Ontario K1A 0N9, quoting File No. M4815-10-1.

CLAUDE JACQUES
Secretary

[48-1-o]

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Hazardous Materials Information Review Commission hereby gives notice of the decision of the Screening Officer, respecting each claim for exemption, and the relevant Material Safety Data Sheets (MSDSs), listed below.

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	MSDS Preparation Date (As shown on the MSDS)	Date of Decision
The Lubrizol Corporation, Wickliffe, Ohio	ANGLAMOL ® 6063A formerly/ antérieurement Lubrizol 6063A	3093	02 April 2004	September 17, 2004 le 17 septembre 2004
CYTEC Industries, Inc., West Paterson, New Jersey	FM+ 641 Verifilm	4682	11/16/2001	October 8, 2004 le 8 octobre 2004
CYTEC Industries, Inc., West Paterson, New Jersey	FM+ 643 Verifilm	4683	11/16/2001	October 8, 2004 le 8 octobre 2004
Infineum USA LP, Linden, New Jersey	Infineum T4213 formerly/ antérieurement Infineum T4213 (PARATORQ 4213)	4819	July 19, 2000	August 27, 2004 le 27 août 2004
Infineum USA LP, Linden, New Jersey	Infineum T4214 formerly/ antérieurement Infineum T4214 (PARATORQ 4214)	4820	July 19, 2000	August 27, 2004 le 27 août 2004
Infineum USA LP, Linden, New Jersey	Infineum T4219 formerly/ antérieurement Infineum T4219 (PARATORQ 4219)	4821	May 2, 2000	August 27, 2004 le 27 août 2004
Infineum USA LP, Linden, New Jersey	Infineum D3948 formerly/ antérieurement Infineum D3948 (PARATORQ 3948)	4876	October 26, 2000	September 23, 2004 le 23 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	CRO396 CORROSION INHIBITOR formerly/ antérieurement CRO396F	4878	1/25/2003	August 4, 2004 le 4 août 2004
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL ® 9220	4952	04 October 2002	August 17, 2004 le 17 août 2004
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL ® 6178	4953	19 February 2003	September 24, 2004 le 24 septembre 2004
The Lubrizol Corporation, Wickliffe, Ohio	ANGLAMOL ® 6091	4954	28 February 2003	September 24, 2004 le 24 septembre 2004
Resolution Performance Products, Houston, Texas	EPIKURE (TM) 8537-WY-60 Curing Agent formerly/ antérieurement EPI-CURE(R) 8537-WY-60 CURING AGENT	4955	03/04/2003	August 19, 2004 le 19 août 2004
Shlumberger, Sugar Land, Texas	SLURRIABLE CROSSLINK ACTIVATOR J465	4969	28-September-2002	August 10, 2004 le 10 août 2004
Hercules Canada (2002) Inc., formerly/ antérieurement Hercules Canada, Mississauga, Ontario	HERCULES® 247 RELEASE AGENT	4981	23-Jun-2003	August 20, 2004 le 20 août 2004
Cognis Canada Corporation, Mississauga, Ontario	STABILOL HCN CONC currently/ actuellement STABILOL MS	4995	03212001	September 28, 2004 le 28 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	CRW9139 CORROSION INHIBITOR	4998	7/1/2003	August 24, 2004 le 24 août 2004
Baker Petrolite Corp., Sugar Land, Texas	CRW9996 CORROSION INHIBITOR	4999	7/1/2003	August 24, 2004 le 24 août 2004
ATOFINA Canada Inc., Oakville, Ontario	THERMOLITE® 172	5073	04/18/01	August 4, 2004 le 4 août 2004
ATOFINA Canada Inc., Oakville, Ontario	THERMOLITE® 178	5074	04/18/01	August 4, 2004 le 4 août 2004
ATOFINA Canada Inc., Oakville, Ontario	THERMOLITE® 380	5088	04/16/01	August 4, 2004 le 4 août 2004
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL (R) 8563B	5091	04 October 2002	September 17, 2004 le 17 septembre 2004
Infineum USA LP, Linden, New Jersey	Infineum T4540	5106	May 15, 2000	August 25, 2004 le 25 août 2004
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMEEN ® PF-53W° formerly/ antérieurement ARMEEN® PF-53W	5112	09/30/2003	September 15, 2004 le 15 septembre 2004
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	ARMEEN ® PF-52H° formerly/ antérieurement ARMEEN® PF-52H	5113	09/30/2003	September 15, 2004 le 15 septembre 2004
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	LILAFLOT ® 1590 formerly/ antérieurement Lilaflot ® 1590	5114	10/1/2003	October 13, 2004 le 13 octobre 2004
Cognis Canada Corporation, Mississauga, Ontario	TEXAPHOR 963	5132	10/09/2003	October 14, 2004 le 14 octobre 2004
Baker Petrolite Corp., Sugar Land, Texas	LT Gelled Oil Breaker B146	5203	24-April-2003	August 31, 2004 le 31 août 2004
Baker Petrolite Corp., Sugar Land, Texas	PAO2343	5214	2/25/2004	September 3, 2004 le 3 septembre 2004
Crompton Co./Cie., Elmira, Ontario	ROYALAC® 150	5230	August 1, 2003 (English/ anglaise) 1 août 2003 (French/ française)	October 18, 2004 le 18 octobre 2004
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® C-462	5232	12/16/2003	August 4, 2004 le 4 août 2004
Baker Petrolite Corp., Sugar Land, Texas	DMO2532 DEMULSIFIER formerly/ antérieurement DMO2532G	5234	1/6/2004	August 30, 2004 le 30 août 2004
CYTEC Industries, Inc., West Paterson, New Jersey	BR+ 6747-1 Water Based Primer, 10-70% Solids currently/ actuellement BR+ 6747-1 Water Based Primer, 20-40 % Solids	5243	10/15/2001	October 8, 2004 le 8 octobre 2004
Dow Chemical Canada Inc., Varennes, Québec	TRITON(TM) DF-20 SURFACTANT/ SURFACTIF TRITON(MD) DF-20	5270	2001.11.16	October 14, 2004 le 14 octobre 2004
Baker Petrolite Corp., Sugar Land, Texas	CRO203 CORROSION INHIBITOR formerly/ antérieurement CRO0203F CORROSION INHIBITOR	5280	8/14/2002	September 21, 2004 le 21 septembre 2004
BYK-Chemie USA, Inc., Wallingford, Connecticut	Anti-Terra-U	5293	01/01/2002	October 7, 2004 le 7 octobre 2004
BYK-Chemie USA, Inc., Wallingford, Connecticut	BYK-W 920	5294	01/01/2002	October 7, 2004 le 7 octobre 2004
Cognis Canada Corporation, Mississauga, Ontario	EMERY 6760L	5342	01/30/2002	September 16, 2004 le 16 septembre 2004
Crompton Co./Cie., Elmira, Ontario	ROYALAC® 150 POWDER	5351	August 1, 2003 (English/ anglaise) 1 août 2003 (French/ française)	October 18, 2004 le 18 octobre 2004
Baker Petrolite Corp., Sugar Land, Texas	TOLAD® 9131 ADDITIVE	5410	8/14/2002	August 27, 2004 le 27 août 2004
Baker Petrolite Corp., Sugar Land, Texas	SULFIX® 9200 SCAVENGER	5416	12/4/2003	September 3, 2004 le 3 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	Carbo-Mul	5438	6/28/2002	August 26, 2004 le 26 août 2004
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® C-320	5445	12/16/2003	September 29, 2004 le 29 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	AQUET 944	5456	6/30/2003	September 21, 2004 le 21 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	BPR 39710	5467	9/12/2002	September 23, 2004 le 23 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	HI-M-PACT™ 4136 Hydrate Inhibitor formerly/ antérieurement HI-M-PACT (TM) 4136	5468	10/21/2003	September 23, 2004 le 23 septembre 2004
Baker Petrolite Corp., Sugar Land, Texas	HI-M-PACT™ 4394 Hydrate Inhibitor formerly/ antérieurement HI-M-PACT (TM) 4394	5472	1/9/2004	October 5, 2004 le 5 octobre 2004
CESI Chemicals, Marlow, Oklahoma	MA-844W	5516	20/12/02	October 1, 2004 le 1er octobre 2004
BASF Canada Inc., Toronto, Ontario	Plurafac SLF-18B-45	5547	2003-01-20	October 12, 2004 le 12 octobre 2004
Cognis Canada Corporation, Mississauga, Ontario	DACOSPIN 2152-P	5565	03/06/2003	October 7, 2004 le 7 octobre 2004
GE Canada Inc., Mississauga, Ontario	Niax® Silicone L-560	5815	10/23/2003	October 5, 2004 le 5 octobre 2004
GE Canada Inc., Mississauga, Ontario	Niax® Silicone L-618 formerly/ antérieurement Niax® silicone L-618	5818	10/23/2003	October 5, 2004 le 5 octobre 2004

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on February 12, 1994, listed the subject of the claim bearing Registry Number 3093 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of four ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on February 3, 2001, listed the subject of the claim bearing Registry Number 4876 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.

3. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4954 to be the chemical identity of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.

4. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4981 to be the chemical identity of two ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.

5. The Notice of Filing published in the Canada Gazette, Part I, on May 5, 2001, listed the subject of the claim bearing Registry Number 4995 to be the chemical identity and concentration of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity and concentration of two ingredients.

6. The Notice of Filing published in the Canada Gazette, Part I, on August 18, 2001, listed the subject of the claims bearing Registry Numbers 5112 and 5114 to be the chemical identity and concentration of two ingredients. The subject of the claims on which the Screening Officer issued the decisions is the chemical identity of two ingredients.

7. The Notice of Filing published in the Canada Gazette, Part I, on August 18, 2001, listed the subject of the claim bearing Registry Number 5113 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of three ingredients.

8. The Notice of Filing published in the Canada Gazette, Part I, on November 3, 2001, listed the subject of the claim bearing Registry Number 5230 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of one ingredient.

9. The Notice of Filing published in the Canada Gazette, Part I, on January 19, 2002, listed the subject of the claim bearing Registry Number 5243 to be the chemical identity of four ingredients. The subject of the claim on which the Screening Officer issued the decision is the chemical identity of five ingredients.

There were no submissions from affected parties to the Screening Officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid with the exception of the claim bearing registry number 5516 which was found to be partially valid. The Screening Officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to each claim did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the Screening Officer found that the respective MSDS relating to the remaining claims did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Number 3093

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. Disclose the percent concentration of substituted thiadiazole in an acceptable manner;

3. Correct the implication that 1,2,4-trimethylbenzene is an ingredient of the controlled product;

4. Disclose that the olefin sulfide is a skin sensitizer.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 4682 and 4683

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

3. Amend the MSDS to describe the subheading Odour Threshold as "not applicable";

4. Disclose a lower LD₅₀ (oral, female rat) value of 4 328 mg/kg for toluene;

5. Disclose the synergistic potential of manganese and halogenated hydrocarbons.

Registry Numbers 4819 to 4821, inclusive

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Value ACGIH TLV-STEL = 10 mg/m³ (mineral oil mist);

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water or milk to drink;

3. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 4876

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of alkylated aryl sufonate, Ca salt in an acceptable manner;

2. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

3. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

4. Identify the ACGIH Exposure Limit Value of 5 mg/m³ shown on the MSDS for oil mists as being a "TWA-TLV" value and add the Exposure Limit Value ACGIH TLV-STEL = 10 mg/m³;

5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water or milk to drink.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4878

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropyl alcohol;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Disclose an LD₅₀ (oral, rat) value of 6.0 mL/kg and an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

4. Disclose a lower LD₅₀ (oral, female rat) value of 4 328 mg/kg for toluene;

5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause arteriosclerosis in laboratory animals;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals;

7. Disclose an oral LD₅₀ range value for one of the confidential hazardous ingredients.

Registry Number 4952

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15 minutes or until the chemical is removed.

Registry Number 4953

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of alkenyl phosphite in an acceptable manner.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4954

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

3. Remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4955

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, male rat) value of 3 089 mg/kg, an LD₅₀ (dermal, rabbit) value of 870 mg/kg and an LC₅₀ (4 hours, vapour, mouse) value of 2 024 ppm for 2-propoxyethanol;

2. Disclose an LD₅₀ (oral, rat) value of 3 530 mg/kg, an LD₅₀ (dermal, guinea pig) value of 3 400 mg/kg and an LC₅₀ (4 hours, mouse) value of 2 810 ppm for acetic acid;

3. Disclose that an ingredient in the controlled product has been shown to cause fetotoxicity in laboratory animals.

Registry Number 4969

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Revise the MSDS to show that crystalline silica has been classified as carcinogenic to humans (Group 1) by the International Agency for Research on Cancer (IARC) and has been classified as a suspected human carcinogen (A2) by the American Conference of Governmental Industrial Hygienists (ACGIH);

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to induce vomiting and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

3. Add phosphorus pentachloride to the list of incompatible materials;

4. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

5. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 4981

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional confidential hazardous ingredient in the controlled product;

2. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its CAS Registry Number and percent concentration;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "If conscious, drink water or milk to dilute the material";

5. Disclose that inhalation of an ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals at maternally toxic dose levels;

6. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals in the absence of maternal toxic effects;

7. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 4995

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye corrosion in laboratory animals;

2. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on bone growth in laboratory animals;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes;

4. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water;

5. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 4998 and 4999

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–60 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed continuously with lukewarm, gently flowing water for at least 20–60 minutes. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

5. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

6. Disclose that the controlled product is incompatible with alkylaluminum solutions, boron trichloride, cyanuric chloride, diethylzinc, aluminum and magnesium metals, phosphorus III oxide, potassium t-butoxide and phosphorus pentasulfide;

7. Disclose that ingestion of an ingredient in the controlled product has caused adverse CNS effects, gastrointestinal effects and produced blurred vision and blindness;

8. Disclose an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropyl alcohol;

9. Disclose the value of an upper bound for the LC₅₀ value for monoethanolamine;

10. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause damage to the pancreas in laboratory animals;

11. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo;

12. Disclose that acute inhalation of an ingredient in the controlled product may cause adverse vision system effects;

13. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the testes of laboratory animals;

14. Disclose that ingredients in the controlled product has been shown to cause fetotoxicity in laboratory animals;

15. Disclose that ingestion of an ingredient in the controlled product has been shown to cause sperm effects in laboratory animals.

Registry Numbers 5073 and 5074

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Value ACGIH TLV-STEL = 0.2 mg/m³ (as Sn) for the confidential hazardous ingredient tin, butyl mixed thio complexes;

2. Add oxides of sulphur to the list of hazardous combustion products;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "otherwise, give 2 glasses of water or milk".

Registry Number 5088

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Value ACGIH TLV-STEL = 0.2 mg/m³ (as Sn) for the confidential hazardous ingredients tin, butyl mixed thio complexes and monobutyltin trichloride;

2. Add oxides of sulphur to the list of hazardous combustion products;

3. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

5. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "otherwise, give 2 glasses of water or milk".

Registry Number 5091

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5106

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Value ACGIH TLV-STEL = 10 mg/m³ (mineral oil mist);

2. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give water or milk to drink;

3. Add oxides of nitrogen to the list of hazardous combustion products.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 5112 and 5113

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 15 minutes or until the chemical is removed.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the Screening Officer.

Registry Number 5114

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 20–30 minutes while taking care not to rinse contaminated water into the unaffected eye or face;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for 20–30 minutes;

3. In relation to the first aid information shown on the MSDS for ingestion, clarify that fluid is to be administered only under medical supervision. Add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropanol;

5. Disclose that an ingredient in the controlled product is incompatible with 2-butanone, aluminum and potassium tert-butoxide;

6. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

7. Disclose an LD₅₀ (oral, rat) value of 4 710 mg/kg and an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

8. Disclose information on the irritancy of the controlled product in a consistent manner;

9. Disclose that ingestion of an ingredient in the controlled product can cause adverse central nervous system (CNS) effects and gastrointestinal disturbances in humans;

10. Disclose that acute inhalation of high doses of an ingredient in the controlled product has been shown to cause adverse lung effects and that chronic inhalation has been shown to cause testicular and kidney effects in laboratory animals;

11. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals and that ingestion of that same ingredient has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

12. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5132

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose oxides of carbon and nitrogen as hazardous combustion products.

Registry Number 5203

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of mineral oil in the controlled product, its CAS Registry Number 64741-53-3 and its percent concentration;

2. Disclose that an ingredient in the controlled product has been classified as carcinogenic to humans (Group 1) by the International Agency for Research on Cancer (IARC);

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–30 minutes;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes;

5. Disclose that acute exposure to an ingredient in the controlled product can be corrosive to the eyes and skin;

6. Disclose that dermal exposure to an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals;

7. Disclose an LD₅₀ value for the confidential hazardous ingredient in an acceptable manner;

8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D2A and E.

Registry Number 5214

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in classes D1B and E;

2. Disclose the Exposure Limit Value AIHA WEEL-TWA = 1 ppm (skin) for triethylenetetramine;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–30 minutes;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for at least 20–30 minutes;

5. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

6. Disclose an LD₅₀ (dermal, rabbit) value of 549 mg/kg for triethylenetetramine;

7. Disclose that an ingredient in the controlled product has been shown to cause skin and eye corrosion in laboratory animals.

Registry Number 5230

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water.

Registry Number 5232

The claimant has been ordered to amend certain aspects of the format of the MSDS.

Registry Number 5234

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system depression in laboratory animals.

Registry Number 5243

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of two of the confidential hazardous ingredients in an acceptable manner;

2. Disclose the generic chemical identity for the additional confidential hazardous ingredient in the controlled product, together with the actual concentration or an acceptable range value;

3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed;

5. Amend the MSDS to describe the subheading Odour Threshold as "not applicable";

6. Disclose an LD₅₀ value for one of the confidential hazardous ingredients in an acceptable manner;

7. Disclose that ingredients in the controlled product have been shown to cause respiratory sensitization in workers;

8. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D1B.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5270

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "If the patient is fully conscious, give two glasses of water";

2. Disclose information on the irritancy of the controlled product in a consistent manner.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5280

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product;

2. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropyl alcohol;

3. Disclose the Exposure Limit Values ACGIH TLV-TWA = 5 mg/m³ and ACGIH TLV-STEL = 10 mg/m³ (mineral oil mist);

4. Disclose the Exposure Limit Value OSHA PEL = 100 ppm for isobutanol;

5. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause CNS effects;

6. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15 minutes or until the chemical is removed;

7. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

8. Disclose an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

9. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals;

10. Disclose that subchronic dermal exposure to an ingredient in the controlled product has been shown to cause adverse effects on the bone marrow and liver in laboratory animals;

11. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro;

12. Disclose that an ingredient in the controlled product has been classified as carcinogenic to humans (Group 1) by the International Agency for Research on Cancer (IARC).

Registry Numbers 5293 and 5294

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has been shown to cause eye irritation in laboratory animals.

Registry Number 5342

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water.

Registry Number 5351

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to drink water.

Registry Number 5410

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause central nervous system depression in laboratory animals.

Registry Number 5416

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that ethylbenzene and naphthalene are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with lukewarm, gently flowing water for at least 20–30 minutes;

3. Disclose that an ingredient in the controlled product is incompatible with acetic acid;

4. Disclose an LD₅₀ (oral, rat) value of 3 523 mg/kg for xylene;

5. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity and postnatal developmental toxicity in laboratory animals;

6. Disclose that hexane synergistically enhances the hearing loss caused by inhalation exposure to xylene in laboratory animals.

Registry Number 5438

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Disclose that the controlled product is incompatible with alkylaluminum solutions, boron trichloride, cyanuric chloride, diethylzinc, aluminum and magnesium metals, phosphorus III oxide and potassium t-butoxide;

4. Disclose an LC₅₀ (4 hours, rat) value of 50 000 ppm for methanol;

5. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause adverse gastrointestinal, vision and CNS effects, prolonged coma and respiratory failure as well as necrosis and haemorrhaging in the brain;

6. Disclose that dermal absorption of an ingredient in the controlled product has caused adverse gastrointestinal, vision and CNS effects;

7. Disclose that chronic inhalation of an ingredient in the controlled product has caused diminished vision and gastrointestinal effects in humans and that it has been shown to cause liver effects in laboratory animals;

8. Disclose that an ingredient in the controlled product has been shown to be mutagenic, in vivo.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5445

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Number 5456

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose that acute ingestion of an ingredient of the controlled product has been shown to cause adverse CNS effects and gastrointestinal tract disturbances;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Add aluminum powder to the list of incompatible materials;

4. Disclose an LC₅₀ (4 hours, rat) value of 16 970 ppm for isopropanol;

5. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular effects in laboratory animals.

Registry Number 5467

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that xylene and trimethylbenzenes are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

3. Disclose an LD₅₀ range value for the confidential hazardous ingredient in an acceptable manner.

Registry Number 5468

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer cardiopulmonary resuscitation if the heart has stopped;

3. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, beryllium hydride, boron trichloride, cyanuric chloride, phosphorus III oxide and potassium tert-butoxide;

5. Disclose that acute ingestion of an ingredient in the controlled product has been shown to cause adverse vision effects as well as necrosis and haemorrhaging in the brain;

6. Disclose that acute dermal exposure to an ingredient in the controlled product has been shown to cause adverse vision effects;

7. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 5472

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Add chloride ion fumes to the list of hazardous decomposition products;

4. Disclose that an ingredient in the controlled product is incompatible with acetyl bromide, aluminum and magnesium metals, aluminum and zinc salts, boron trichloride, cyanuric chloride;

5. Disclose that acute ingestion of an ingredient in the controlled product has caused adverse vision effects as well as necrosis and haemorrhaging in the brain;

6. Disclose that acute inhalation and dermal exposure to an ingredient in the controlled product have caused adverse vision and CNS effects;

7. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in mammalian cells, in vitro.

Registry Number 5516

The claimant has been ordered to amend certain aspects of the content and wording of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the Exposure Limit Values ACGIH TLV-TWA = 200 ppm and ACGIH TLV-STEL = 400 ppm for isopropanol;

2. Disclose an LC₅₀ (4 hours, rat) value of 17 000 ppm for isopropanol;

3. Disclose an LD₅₀ (oral, rat) value of 4.4 g/kg for cyclohexenes;

4. Disclose the Exposure Limit Value AIHA WEEL-TWA = 30 ppm for cyclohexenes;

5. Disclose LD₅₀ values for one of the confidential hazardous ingredients in an acceptable manner;

6. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

7. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15 minutes or until the chemical is removed;

8. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink;

9. Disclose that metal containers should be grounded when transferring quantities of the controlled product;

10. Disclose that the controlled product is incompatible with aluminum powder and sulfur;

11. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause testicular and kidney effects in laboratory animals;

12. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxic effects in laboratory animals and that ingestion of that same ingredient has been shown to cause fetotoxic effects in laboratory animals at maternally toxic dose levels;

13. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity;

14. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Registry Number 5547

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, delete the statements to give water to drink and to induce vomiting.

Registry Number 5565

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the Screening Officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with soap and water for 20 minutes or until the chemical is removed.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the Screening Officer.

Registry Numbers 5815 and 5818

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Having regard to the foregoing, and pursuant to sections 16 and 17 of the Hazardous Materials Information Review Act, notice is hereby given that the Screening Officer has, for the claim bearing registry number 5516, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, including disclosing the identity of one ingredient which was included among the information in respect of which the claim for exemption was made, and to provide a copy of the amended MSDS to the Screening Officer within 40 days of expiry of the appeal period.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the Screening Officer has, for each of the remaining above-noted claims, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the Screening Officer within 40 days of expiry of the appeal period.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the Screening Officer, should have been shown on the relevant MSDS.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal any decision or order of a Screening Officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, (613) 993-4429.

R. BOARDMAN
Chief Screening Officer

[48-1-o]

INTERNATIONAL JOINT COMMISSION
UNITED STATES AND CANADA

BOUNDARY WATERS TREATY OF 1909

The International Joint Commission releases International Missisquoi Bay Task Force Report and schedules public hearings

The International Joint Commission (IJC) today released the report of its International Missisquoi Bay Task Force and scheduled public hearings to receive comment on the report.

In May of this year, the Canadian and United States federal governments asked the IJC to review plans by the State of Vermont to modernize the Alburg-Swanton Bridge, involving the partial removal of the existing causeway, and to provide advice on whether the plans comply with Article IV of the Boundary Waters Treaty of 1909. Article IV states, in part, that "boundary waters and waters flowing across the boundary shall not be polluted on either side to the injury of health or property on the other."

All interested organizations and citizens are invited to speak at the public hearings to be held at the following times and locations:

Monday, December 6, 2004, from 7 p.m. to 9:30 p.m., at the Centre des loisirs, 1 Tourangeau Street, Saint-Georges-de-Clarenceville, Quebec;

Tuesday, December 7, 2004, from 7 p.m. to 9:30 p.m., at the Missisquoi Valley Union High School, 100 Thunderbird Drive, Swanton, Vermont.

As time will be limited, speakers are encouraged to highlight their comments at the public hearings and provide more detailed comments in writing. Written comments may also be sent to either address below for receipt by January 4, 2005.

Secretary, Canadian Section, 234 Laurier Avenue W, 22nd Floor, Ottawa, Ontario K1P 6K6, facsimile: (613) 993-5583, telephone: (613) 995-2984, electronic mail: Commission@ottawa.ijc.org;

Secretary, United States Section, 1250 23rd Street NW, Suite 100, Washington, DC 20440, facsimile: (202) 467-0746, telephone: (202) 736-9024, electronic mail: Commission@washington.ijc.org.

More information, including the full text of the International Missisquoi Bay Task Force Report, may be found on the Commission's Web site, at www.ijc.org.

[48-1-o]

NAFTA SECRETARIAT

COMPLETION OF PANEL REVIEW

Pure magnesium from Canada

Notice is hereby given, pursuant to rule 79 of the NAFTA Article 1904 Panel Rules, that the binational panel review of the Final Results of the Full Sunset Review of the antidumping duty order made by United States Department of Commerce, International Trade Administration, respecting Pure Magnesium from Canada is completed (Secretariat File No. USA-CDA-2000-1904-06). This notice is effective as of October 8, 2004, the day after the Extraordinary Challenge Committee issued its decision affirming the panel decisions.

In the October 7, 2004 decision, the Extraordinary Challenge Committee (Secretariat File No. ECC-2003-1904-01USA) dismissed the challenge and affirmed the panel decisions in the matter of Pure Magnesium from Canada.

Copies of the complete decision may be obtained from Canadian Government Publishing, Public Works and Government Services Canada, Ottawa, Canada K1A 0S5, (613) 941-5995 or 1-800-635-7943.

Explanatory note

Chapter 19 of the North American Free Trade Agreement establishes a procedure for replacing domestic judicial review of determinations in antidumping and countervailing duty cases involving imports from a NAFTA country with review by binational panels.

These panels are established, when a Request for Panel Review is received by the NAFTA Secretariat, to act in place of national courts to review final determinations expeditiously to determine whether they are in accordance with the antidumping or countervailing duty law of the country that made the determination.

Under Article 1904 of the North American Free Trade Agreement which came into force on January 1, 1994, the Government of Canada, the Government of the United States and the Government of Mexico established the Rules of Procedure for Article 1904 Binational Panel Reviews. These Rules were published in the Canada Gazette, Part I, on January 1, 1994.

Requests for information concerning the present notice, or concerning the NAFTA Article 1904 Panel Rules, should be addressed to the Canadian Secretary, NAFTA Secretariat, Canadian Section, 90 Sparks Street, Suite 705, Ottawa, Ontario K1P 5B4, (613) 992-9388.

FRANÇOY RAYNAULD
Canadian Secretary

[48-1-o]

NOTICE:
The format of the electronic version of this issue of the Canada Gazette was modified in order to be compatible with extensible hypertext markup language (XHTML 1.0 Strict).